 | • レポートコード：MRC2012A0084 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、医療品有効成分の世界市場を広く調査・分析し、今後の市場展望をまとめております。医療品有効成分の種類別市場規模（革新的医薬品有効成分、ジェネリック医薬品有効成分）、用途別市場規模（腫瘍、心血管疾患、糖尿病、中枢神経系・神経障害、内分泌系、その他治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Teva、Roche、Johnson & Johnson、Novartis、Dr. Reddy’s Laboratories、Pfizer、Sun Pharmaceutical Industries、North China Pharmaceutical Group、Mylan、Aurobindo pharma、Zhejiang Medicine、Hisun Pharmacy、Boehringer Ingelheim GmbH、Shandong Xinhua Pharmaceutical、Biocon、DSM、Bayer、Cambrex、Johnson Matthey、BASF、North East Pharmaceutical、Lonza group、Lupin、Tian Yao、Shandong Lukang Pharmaceutical、Cipla、Jiangsu Hengrui Medicine、Huahai Pharmaceutical、Albemarle、Haerbin Pharmaceutical Group、 ・地域別グローバル市場分析 2015年-2020年 ・医療品有効成分の北米市場（アメリカ、カナダ、メキシコ） ・医療品有効成分のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・医療品有効成分のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・医療品有効成分の南米市場（ブラジル、アルゼンチン） ・医療品有効成分の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：革新的医薬品有効成分、ジェネリック医薬品有効成分 ・用途別分析：腫瘍、心血管疾患、糖尿病、中枢神経系・神経障害、内分泌系、その他治療 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Active Pharma Ingredient market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Active Pharma Ingredient market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Active Pharma Ingredient market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Active Pharma Ingredient market has been segmented into
Innovative Active Pharmaceutical Ingredients
Generic Active Pharmaceutical Ingredients
By Application, Active Pharma Ingredient has been segmented into:
Oncology
Cardiovascular Disease
Diabetes
Central Nervous System and Neurological Disorders
Endocrinology
Other Therapeutic Applications
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Active Pharma Ingredient market presented in the report. This section sheds light on the sales growth of different regional and country-level Active Pharma Ingredient markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Active Pharma Ingredient market.
The report offers in-depth assessment of the growth and other aspects of the Active Pharma Ingredient market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Active Pharma Ingredient Market Share Analysis
Active Pharma Ingredient competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Active Pharma Ingredient sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Active Pharma Ingredient sales, revenue and market share for each player covered in this report.
The major players covered in Active Pharma Ingredient are:
Teva
Roche
Johnson & Johnson
Novartis
Dr. Reddy’s Laboratories
Pfizer
Sun Pharmaceutical Industries
North China Pharmaceutical Group
Mylan
Aurobindo pharma
Zhejiang Medicine
Hisun Pharmacy
Boehringer Ingelheim GmbH
Shandong Xinhua Pharmaceutical
Biocon
DSM
Bayer
Cambrex
Johnson Matthey
BASF
North East Pharmaceutical
Lonza group
Lupin
Tian Yao
Shandong Lukang Pharmaceutical
Cipla
Jiangsu Hengrui Medicine
Huahai Pharmaceutical
Albemarle
Haerbin Pharmaceutical Group
Among other players domestic and global, Active Pharma Ingredient market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Active Pharma Ingredient product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Active Pharma Ingredient, with price, sales, revenue and global market share of Active Pharma Ingredient in 2018 and 2019.
Chapter 3, the Active Pharma Ingredient competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Active Pharma Ingredient breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Active Pharma Ingredient market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Active Pharma Ingredient sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Active Pharma Ingredient Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Active Pharma Ingredient Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Innovative Active Pharmaceutical Ingredients
1.2.3 Generic Active Pharmaceutical Ingredients
1.3 Market Analysis by Application
1.3.1 Overview: Global Active Pharma Ingredient Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiovascular Disease
1.3.4 Diabetes
1.3.5 Central Nervous System and Neurological Disorders
1.3.6 Endocrinology
1.3.7 Other Therapeutic Applications
1.4 Overview of Global Active Pharma Ingredient Market
1.4.1 Global Active Pharma Ingredient Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva SWOT Analysis
2.1.4 Teva Product and Services
2.1.5 Teva Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Dr. Reddy’s Laboratories
2.5.1 Dr. Reddy’s Laboratories Details
2.5.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Dr. Reddy’s Laboratories SWOT Analysis
2.5.4 Dr. Reddy’s Laboratories Product and Services
2.5.5 Dr. Reddy’s Laboratories Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sun Pharmaceutical Industries
2.7.1 Sun Pharmaceutical Industries Details
2.7.2 Sun Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sun Pharmaceutical Industries SWOT Analysis
2.7.4 Sun Pharmaceutical Industries Product and Services
2.7.5 Sun Pharmaceutical Industries Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 North China Pharmaceutical Group
2.8.1 North China Pharmaceutical Group Details
2.8.2 North China Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 North China Pharmaceutical Group SWOT Analysis
2.8.4 North China Pharmaceutical Group Product and Services
2.8.5 North China Pharmaceutical Group Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mylan SWOT Analysis
2.9.4 Mylan Product and Services
2.9.5 Mylan Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Aurobindo pharma
2.10.1 Aurobindo pharma Details
2.10.2 Aurobindo pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Aurobindo pharma SWOT Analysis
2.10.4 Aurobindo pharma Product and Services
2.10.5 Aurobindo pharma Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Zhejiang Medicine
2.11.1 Zhejiang Medicine Details
2.11.2 Zhejiang Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Zhejiang Medicine SWOT Analysis
2.11.4 Zhejiang Medicine Product and Services
2.11.5 Zhejiang Medicine Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Hisun Pharmacy
2.12.1 Hisun Pharmacy Details
2.12.2 Hisun Pharmacy Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Hisun Pharmacy SWOT Analysis
2.12.4 Hisun Pharmacy Product and Services
2.12.5 Hisun Pharmacy Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Boehringer Ingelheim GmbH
2.13.1 Boehringer Ingelheim GmbH Details
2.13.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Boehringer Ingelheim GmbH SWOT Analysis
2.13.4 Boehringer Ingelheim GmbH Product and Services
2.13.5 Boehringer Ingelheim GmbH Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Shandong Xinhua Pharmaceutical
2.14.1 Shandong Xinhua Pharmaceutical Details
2.14.2 Shandong Xinhua Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Shandong Xinhua Pharmaceutical SWOT Analysis
2.14.4 Shandong Xinhua Pharmaceutical Product and Services
2.14.5 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Biocon
2.15.1 Biocon Details
2.15.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Biocon SWOT Analysis
2.15.4 Biocon Product and Services
2.15.5 Biocon Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 DSM
2.16.1 DSM Details
2.16.2 DSM Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 DSM SWOT Analysis
2.16.4 DSM Product and Services
2.16.5 DSM Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bayer
2.17.1 Bayer Details
2.17.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bayer SWOT Analysis
2.17.4 Bayer Product and Services
2.17.5 Bayer Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Cambrex
2.18.1 Cambrex Details
2.18.2 Cambrex Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Cambrex SWOT Analysis
2.18.4 Cambrex Product and Services
2.18.5 Cambrex Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Johnson Matthey
2.19.1 Johnson Matthey Details
2.19.2 Johnson Matthey Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Johnson Matthey SWOT Analysis
2.19.4 Johnson Matthey Product and Services
2.19.5 Johnson Matthey Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 BASF
2.20.1 BASF Details
2.20.2 BASF Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 BASF SWOT Analysis
2.20.4 BASF Product and Services
2.20.5 BASF Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 North East Pharmaceutical
2.21.1 North East Pharmaceutical Details
2.21.2 North East Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 North East Pharmaceutical SWOT Analysis
2.21.4 North East Pharmaceutical Product and Services
2.21.5 North East Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.22 Lonza group
2.22.1 Lonza group Details
2.22.2 Lonza group Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Lonza group SWOT Analysis
2.22.4 Lonza group Product and Services
2.22.5 Lonza group Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.23 Lupin
2.23.1 Lupin Details
2.23.2 Lupin Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Lupin SWOT Analysis
2.23.4 Lupin Product and Services
2.23.5 Lupin Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.24 Tian Yao
2.24.1 Tian Yao Details
2.24.2 Tian Yao Major Business and Total Revenue (Financial Highlights) Analysis
2.24.3 Tian Yao SWOT Analysis
2.24.4 Tian Yao Product and Services
2.24.5 Tian Yao Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.25 Shandong Lukang Pharmaceutical
2.25.1 Shandong Lukang Pharmaceutical Details
2.25.2 Shandong Lukang Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.25.3 Shandong Lukang Pharmaceutical SWOT Analysis
2.25.4 Shandong Lukang Pharmaceutical Product and Services
2.25.5 Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.26 Cipla
2.26.1 Cipla Details
2.26.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.26.3 Cipla SWOT Analysis
2.26.4 Cipla Product and Services
2.26.5 Cipla Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.27 Jiangsu Hengrui Medicine
2.27.1 Jiangsu Hengrui Medicine Details
2.27.2 Jiangsu Hengrui Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.27.3 Jiangsu Hengrui Medicine SWOT Analysis
2.27.4 Jiangsu Hengrui Medicine Product and Services
2.27.5 Jiangsu Hengrui Medicine Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.28 Huahai Pharmaceutical
2.28.1 Huahai Pharmaceutical Details
2.28.2 Huahai Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.28.3 Huahai Pharmaceutical SWOT Analysis
2.28.4 Huahai Pharmaceutical Product and Services
2.28.5 Huahai Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.29 Albemarle
2.29.1 Albemarle Details
2.29.2 Albemarle Major Business and Total Revenue (Financial Highlights) Analysis
2.29.3 Albemarle SWOT Analysis
2.29.4 Albemarle Product and Services
2.29.5 Albemarle Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.30 Haerbin Pharmaceutical Group
2.30.1 Haerbin Pharmaceutical Group Details
2.30.2 Haerbin Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.30.3 Haerbin Pharmaceutical Group SWOT Analysis
2.30.4 Haerbin Pharmaceutical Group Product and Services
2.30.5 Haerbin Pharmaceutical Group Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Active Pharma Ingredient Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Active Pharma Ingredient Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Active Pharma Ingredient Manufacturer Market Share in 2019
3.3.2 Top 6 Active Pharma Ingredient Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Active Pharma Ingredient Sales, Revenue and Market Share by Regions
4.1.1 Global Active Pharma Ingredient Sales and Market Share by Regions (2015-2020)
4.1.2 Global Active Pharma Ingredient Revenue and Market Share by Regions (2015-2020)
4.2 North America Active Pharma Ingredient Sales and Growth Rate (2015-2020)
4.3 Europe Active Pharma Ingredient Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Active Pharma Ingredient Sales and Growth Rate (2015-2020)
4.5 South America Active Pharma Ingredient Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Active Pharma Ingredient Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Active Pharma Ingredient Sales, Revenue and Market Share by Country
5.1.1 North America Active Pharma Ingredient Sales and Market Share by Country (2015-2020)
5.1.2 North America Active Pharma Ingredient Revenue and Market Share by Country (2015-2020)
5.2 United States Active Pharma Ingredient Sales and Growth Rate (2015-2020)
5.3 Canada Active Pharma Ingredient Sales and Growth Rate (2015-2020)
5.4 Mexico Active Pharma Ingredient Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Active Pharma Ingredient Sales, Revenue and Market Share by Country
6.1.1 Europe Active Pharma Ingredient Sales and Market Share by Country (2015-2020)
6.1.2 Europe Active Pharma Ingredient Revenue and Market Share by Country (2015-2020)
6.2 Germany Active Pharma Ingredient Sales and Growth Rate (2015-2020)
6.3 UK Active Pharma Ingredient Sales and Growth Rate (2015-2020)
6.4 France Active Pharma Ingredient Sales and Growth Rate (2015-2020)
6.5 Russia Active Pharma Ingredient Sales and Growth Rate (2015-2020)
6.6 Italy Active Pharma Ingredient Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Active Pharma Ingredient Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Active Pharma Ingredient Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Active Pharma Ingredient Revenue and Market Share by Regions (2015-2020)
7.2 China Active Pharma Ingredient Sales and Growth Rate (2015-2020)
7.3 Japan Active Pharma Ingredient Sales and Growth Rate (2015-2020)
7.4 Korea Active Pharma Ingredient Sales and Growth Rate (2015-2020)
7.5 India Active Pharma Ingredient Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Active Pharma Ingredient Sales and Growth Rate (2015-2020)
7.7 Australia Active Pharma Ingredient Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Active Pharma Ingredient Sales, Revenue and Market Share by Country
8.1.1 South America Active Pharma Ingredient Sales and Market Share by Country (2015-2020)
8.1.2 South America Active Pharma Ingredient Revenue and Market Share by Country (2015-2020)
8.2 Brazil Active Pharma Ingredient Sales and Growth Rate (2015-2020)
8.3 Argentina Active Pharma Ingredient Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Active Pharma Ingredient Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Active Pharma Ingredient Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Active Pharma Ingredient Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Active Pharma Ingredient Sales and Growth Rate (2015-2020)
9.3 Turkey Active Pharma Ingredient Sales and Growth Rate (2015-2020)
9.4 Egypt Active Pharma Ingredient Sales and Growth Rate (2015-2020)
9.5 South Africa Active Pharma Ingredient Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Active Pharma Ingredient Sales and Market Share by Type (2015-2020)
10.2 Global Active Pharma Ingredient Revenue and Market Share by Type (2015-2020)
10.3 Global Active Pharma Ingredient Price by Type (2015-2020)
11 Global Active Pharma Ingredient Market Segment by Application
11.1 Global Active Pharma Ingredient Sales Market Share by Application (2015-2020)
11.2 Global Active Pharma Ingredient Revenue Market Share by Application (2015-2020)
11.3 Global Active Pharma Ingredient Price by Application (2015-2020)
12 Market Forecast
12.1 Global Active Pharma Ingredient Sales, Revenue and Growth Rate (2021-2025)
12.2 Active Pharma Ingredient Market Forecast by Regions (2021-2025)
12.2.1 North America Active Pharma Ingredient Market Forecast (2021-2025)
12.2.2 Europe Active Pharma Ingredient Market Forecast (2021-2025)
12.2.3 Asia-Pacific Active Pharma Ingredient Market Forecast (2021-2025)
12.2.4 South America Active Pharma Ingredient Market Forecast (2021-2025)
12.2.5 Middle East & Africa Active Pharma Ingredient Market Forecast (2021-2025)
12.3 Active Pharma Ingredient Market Forecast by Type (2021-2025)
12.3.1 Global Active Pharma Ingredient Sales Forecast by Type (2021-2025)
12.3.2 Global Active Pharma Ingredient Market Share Forecast by Type (2021-2025)
12.4 Active Pharma Ingredient Market Forecast by Application (2021-2025)
12.4.1 Global Active Pharma Ingredient Sales Forecast by Application (2021-2025)
12.4.2 Global Active Pharma Ingredient Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Active Pharma Ingredient Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Active Pharma Ingredient by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Active Pharma Ingredient Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Active Pharma Ingredient Major Business
Table 9. Teva Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 10. Teva SWOT Analysis
Table 11. Teva Active Pharma Ingredient Product and Services
Table 12. Teva Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche Active Pharma Ingredient Major Business
Table 15. Roche Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 16. Roche SWOT Analysis
Table 17. Roche Active Pharma Ingredient Product and Services
Table 18. Roche Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Active Pharma Ingredient Major Business
Table 21. Johnson & Johnson Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 22. Johnson & Johnson SWOT Analysis
Table 23. Johnson & Johnson Active Pharma Ingredient Product and Services
Table 24. Johnson & Johnson Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis Basic Information, Manufacturing Base and Competitors
Table 26. Novartis Active Pharma Ingredient Major Business
Table 27. Novartis Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 28. Novartis SWOT Analysis
Table 29. Novartis Active Pharma Ingredient Product and Services
Table 30. Novartis Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 32. Dr. Reddy’s Laboratories Active Pharma Ingredient Major Business
Table 33. Dr. Reddy’s Laboratories Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 34. Dr. Reddy’s Laboratories SWOT Analysis
Table 35. Dr. Reddy’s Laboratories Active Pharma Ingredient Product and Services
Table 36. Dr. Reddy’s Laboratories Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Active Pharma Ingredient Major Business
Table 39. Pfizer Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Active Pharma Ingredient Product and Services
Table 42. Pfizer Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharmaceutical Industries Active Pharma Ingredient Major Business
Table 45. Sun Pharmaceutical Industries Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 46. Sun Pharmaceutical Industries SWOT Analysis
Table 47. Sun Pharmaceutical Industries Active Pharma Ingredient Product and Services
Table 48. Sun Pharmaceutical Industries Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. North China Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 50. North China Pharmaceutical Group Active Pharma Ingredient Major Business
Table 51. North China Pharmaceutical Group Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 52. North China Pharmaceutical Group SWOT Analysis
Table 53. North China Pharmaceutical Group Active Pharma Ingredient Product and Services
Table 54. North China Pharmaceutical Group Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Mylan Basic Information, Manufacturing Base and Competitors
Table 56. Mylan Active Pharma Ingredient Major Business
Table 57. Mylan Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 58. Mylan SWOT Analysis
Table 59. Mylan Active Pharma Ingredient Product and Services
Table 60. Mylan Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Aurobindo pharma Basic Information, Manufacturing Base and Competitors
Table 62. Aurobindo pharma Active Pharma Ingredient Major Business
Table 63. Aurobindo pharma Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 64. Aurobindo pharma SWOT Analysis
Table 65. Aurobindo pharma Active Pharma Ingredient Product and Services
Table 66. Aurobindo pharma Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Zhejiang Medicine Basic Information, Manufacturing Base and Competitors
Table 68. Zhejiang Medicine Active Pharma Ingredient Major Business
Table 69. Zhejiang Medicine Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 70. Zhejiang Medicine SWOT Analysis
Table 71. Zhejiang Medicine Active Pharma Ingredient Product and Services
Table 72. Zhejiang Medicine Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Hisun Pharmacy Basic Information, Manufacturing Base and Competitors
Table 74. Hisun Pharmacy Active Pharma Ingredient Major Business
Table 75. Hisun Pharmacy Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 76. Hisun Pharmacy SWOT Analysis
Table 77. Hisun Pharmacy Active Pharma Ingredient Product and Services
Table 78. Hisun Pharmacy Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 80. Boehringer Ingelheim GmbH Active Pharma Ingredient Major Business
Table 81. Boehringer Ingelheim GmbH Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 82. Boehringer Ingelheim GmbH SWOT Analysis
Table 83. Boehringer Ingelheim GmbH Active Pharma Ingredient Product and Services
Table 84. Boehringer Ingelheim GmbH Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Major Business
Table 87. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 88. Shandong Xinhua Pharmaceutical SWOT Analysis
Table 89. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Product and Services
Table 90. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Biocon Basic Information, Manufacturing Base and Competitors
Table 92. Biocon Active Pharma Ingredient Major Business
Table 93. Biocon Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 94. Biocon SWOT Analysis
Table 95. Biocon Active Pharma Ingredient Product and Services
Table 96. Biocon Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. DSM Basic Information, Manufacturing Base and Competitors
Table 98. DSM Active Pharma Ingredient Major Business
Table 99. DSM Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 100. DSM SWOT Analysis
Table 101. DSM Active Pharma Ingredient Product and Services
Table 102. DSM Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Bayer Basic Information, Manufacturing Base and Competitors
Table 104. Bayer Active Pharma Ingredient Major Business
Table 105. Bayer Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 106. Bayer SWOT Analysis
Table 107. Bayer Active Pharma Ingredient Product and Services
Table 108. Bayer Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Cambrex Active Pharma Ingredient Type and Application
Table 110. Cambrex Active Pharma Ingredient Major Business
Table 111. Cambrex Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 112. Cambrex SWOT Analysis
Table 113. Cambrex Active Pharma Ingredient Product and Services
Table 114. Cambrex Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Johnson Matthey Basic Information, Manufacturing Base and Competitors
Table 116. Johnson Matthey Active Pharma Ingredient Major Business
Table 117. Johnson Matthey Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 118. Johnson Matthey SWOT Analysis
Table 119. Johnson Matthey Active Pharma Ingredient Product and Services
Table 120. Johnson Matthey Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. BASF Basic Information, Manufacturing Base and Competitors
Table 122. BASF Active Pharma Ingredient Major Business
Table 123. BASF Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 124. BASF SWOT Analysis
Table 125. BASF Active Pharma Ingredient Product and Services
Table 126. BASF Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. North East Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. North East Pharmaceutical Active Pharma Ingredient Major Business
Table 129. North East Pharmaceutical Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 130. North East Pharmaceutical SWOT Analysis
Table 131. North East Pharmaceutical Active Pharma Ingredient Product and Services
Table 132. North East Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 133. Lonza group Basic Information, Manufacturing Base and Competitors
Table 134. Lonza group Active Pharma Ingredient Major Business
Table 135. Lonza group Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 136. Lonza group SWOT Analysis
Table 137. Lonza group Active Pharma Ingredient Product and Services
Table 138. Lonza group Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 139. Lupin Basic Information, Manufacturing Base and Competitors
Table 140. Lupin Active Pharma Ingredient Major Business
Table 141. Lupin Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 142. Lupin SWOT Analysis
Table 143. Lupin Active Pharma Ingredient Product and Services
Table 144. Lupin Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 145. Tian Yao Basic Information, Manufacturing Base and Competitors
Table 146. Tian Yao Active Pharma Ingredient Major Business
Table 147. Tian Yao Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 148. Tian Yao SWOT Analysis
Table 149. Tian Yao Active Pharma Ingredient Product and Services
Table 150. Tian Yao Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 151. Shandong Lukang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 152. Shandong Lukang Pharmaceutical Active Pharma Ingredient Major Business
Table 153. Shandong Lukang Pharmaceutical Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 154. Shandong Lukang Pharmaceutical SWOT Analysis
Table 155. Shandong Lukang Pharmaceutical Active Pharma Ingredient Product and Services
Table 156. Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 157. Cipla Basic Information, Manufacturing Base and Competitors
Table 158. Cipla Active Pharma Ingredient Major Business
Table 159. Cipla Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 160. Cipla SWOT Analysis
Table 161. Cipla Active Pharma Ingredient Product and Services
Table 162. Cipla Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 163. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 164. Jiangsu Hengrui Medicine Active Pharma Ingredient Major Business
Table 165. Jiangsu Hengrui Medicine Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 166. Jiangsu Hengrui Medicine SWOT Analysis
Table 167. Jiangsu Hengrui Medicine Active Pharma Ingredient Product and Services
Table 168. Jiangsu Hengrui Medicine Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 169. Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 170. Huahai Pharmaceutical Active Pharma Ingredient Major Business
Table 171. Huahai Pharmaceutical Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 172. Huahai Pharmaceutical SWOT Analysis
Table 173. Huahai Pharmaceutical Active Pharma Ingredient Product and Services
Table 174. Huahai Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 175. Albemarle Basic Information, Manufacturing Base and Competitors
Table 176. Albemarle Active Pharma Ingredient Major Business
Table 177. Albemarle Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 178. Albemarle SWOT Analysis
Table 179. Albemarle Active Pharma Ingredient Product and Services
Table 180. Albemarle Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 181. Haerbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 182. Haerbin Pharmaceutical Group Active Pharma Ingredient Major Business
Table 183. Haerbin Pharmaceutical Group Active Pharma Ingredient Total Revenue (USD Million) (2017-2018)
Table 184. Haerbin Pharmaceutical Group SWOT Analysis
Table 185. Haerbin Pharmaceutical Group Active Pharma Ingredient Product and Services
Table 186. Haerbin Pharmaceutical Group Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 187. Global Active Pharma Ingredient Sales by Manufacturer (2018-2019) (MT)
Table 188. Global Active Pharma Ingredient Revenue by Manufacturer (2018-2019) (USD Million)
Table 189. Global Active Pharma Ingredient Sales by Regions (2015-2020) (MT)
Table 190. Global Active Pharma Ingredient Sales Market Share by Regions (2015-2020)
Table 191. Global Active Pharma Ingredient Revenue by Regions (2015-2020) (USD Million)
Table 192. North America Active Pharma Ingredient Sales by Countries (2015-2020) (MT)
Table 193. North America Active Pharma Ingredient Sales Market Share by Countries (2015-2020)
Table 194. North America Active Pharma Ingredient Revenue by Countries (2015-2020) (USD Million)
Table 195. North America Active Pharma Ingredient Revenue Market Share by Countries (2015-2020)
Table 196. Europe Active Pharma Ingredient Sales by Countries (2015-2020) (MT)
Table 197. Europe Active Pharma Ingredient Sales Market Share by Countries (2015-2020)
Table 198. Europe Active Pharma Ingredient Revenue by Countries (2015-2020) (USD Million)
Table 199. Asia-Pacific Active Pharma Ingredient Sales by Regions (2015-2020) (MT)
Table 200. Asia-Pacific Active Pharma Ingredient Sales Market Share by Regions (2015-2020)
Table 201. Asia-Pacific Active Pharma Ingredient Revenue by Regions (2015-2020) (USD Million)
Table 202. South America Active Pharma Ingredient Sales by Countries (2015-2020) (MT)
Table 203. South America Active Pharma Ingredient Sales Market Share by Countries (2015-2020)
Table 204. South America Active Pharma Ingredient Revenue by Countries (2015-2020) (USD Million)
Table 205. South America Active Pharma Ingredient Revenue Market Share by Countries (2015-2020)
Table 206. Middle East & Africa Active Pharma Ingredient Sales by Countries (2015-2020) (MT)
Table 207. Middle East & Africa Active Pharma Ingredient Sales Market Share by Countries (2015-2020)
Table 208. Middle East & Africa Active Pharma Ingredient Revenue by Countries (2015-2020) (USD Million)
Table 209. Middle East & Africa Active Pharma Ingredient Revenue Market Share by Countries (2015-2020)
Table 210. Global Active Pharma Ingredient Sales by Type (2015-2020) (MT)
Table 211. Global Active Pharma Ingredient Sales Share by Type (2015-2020)
Table 212. Global Active Pharma Ingredient Revenue by Type (2015-2020) (USD Million)
Table 213. Global Active Pharma Ingredient Revenue Share by Type (2015-2020)
Table 214. Global Active Pharma Ingredient Sales by Application (2015-2020) (MT)
Table 215. Global Active Pharma Ingredient Sales Share by Application (2015-2020)
Table 216. Global Active Pharma Ingredient Sales Forecast by Regions (2021-2025) (MT)
Table 217. Global Active Pharma Ingredient Market Share Forecast by Regions (2021-2025)
Table 218. Global Active Pharma Ingredient Sales Forecast by Type (2021-2025) (MT)
Table 219. Global Active Pharma Ingredient Market Share Forecast by Type (2021-2025)
Table 220. Global Active Pharma Ingredient Sales Forecast by Application (2021-2025)
Table 221. Global Active Pharma Ingredient Market Share Forecast by Application (2021-2025)
Table 222. Direct Channel Pros & Cons
Table 223. Indirect Channel Pros & Cons
Table 224. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Active Pharma Ingredient Picture
Figure 2. Global Sales Market Share of Active Pharma Ingredient by Type in 2019
Figure 3. Innovative Active Pharmaceutical Ingredients Picture
Figure 4. Generic Active Pharmaceutical Ingredients Picture
Figure 5. Active Pharma Ingredient Sales Market Share by Application in 2018
Figure 6. Oncology Picture
Figure 7. Cardiovascular Disease Picture
Figure 8. Diabetes Picture
Figure 9. Central Nervous System and Neurological Disorders Picture
Figure 10. Endocrinology Picture
Figure 11. Other Therapeutic Applications Picture
Figure 12. Global Active Pharma Ingredient Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Active Pharma Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Active Pharma Ingredient Sales Market Share by Manufacturer in 2019
Figure 33. Global Active Pharma Ingredient Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Active Pharma Ingredient Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Active Pharma Ingredient Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 38. Global Active Pharma Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Active Pharma Ingredient Revenue Market Share by Regions (2015-2020)
Figure 40. Global Active Pharma Ingredient Revenue Market Share by Regions in 2018
Figure 41. North America Active Pharma Ingredient Sales and Growth Rate (2015-2020)
Figure 42. Europe Active Pharma Ingredient Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Active Pharma Ingredient Sales and Growth Rate (2015-2020)
Figure 44. South America Active Pharma Ingredient Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Active Pharma Ingredient Sales and Growth Rate (2015-2020)
Figure 46. North America Active Pharma Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Active Pharma Ingredient Sales Market Share by Countries (2015-2020)
Figure 48. North America Active Pharma Ingredient Sales Market Share by Countries in 2018
Figure 49. North America Active Pharma Ingredient Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Active Pharma Ingredient Revenue Market Share by Countries in 2018
Figure 51. United States Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 52. Canada Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 53. Mexico Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 54. Europe Active Pharma Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Active Pharma Ingredient Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Active Pharma Ingredient Revenue Market Share by Countries in 2019
Figure 57. Germany Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 58. UK Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 59. France Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 60. Russia Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 61. Italy Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 62. Asia-Pacific Active Pharma Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Active Pharma Ingredient Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Active Pharma Ingredient Revenue Market Share by Regions 2019
Figure 65. China Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 66. Japan Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 67. Korea Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 68. India Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 69. Southeast Asia Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 70. South America Active Pharma Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Active Pharma Ingredient Sales Market Share by Countries in 2019
Figure 72. South America Active Pharma Ingredient Revenue Market Share by Countries in 2019
Figure 73. Brazil Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 74. Argentina Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 75. Middle East and Africa Active Pharma Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Active Pharma Ingredient Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Active Pharma Ingredient Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Active Pharma Ingredient Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 80. Egypt Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 81. Turkey Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 82. South Africa Active Pharma Ingredient Sales and Growth Rate (2015-2020) (MT)
Figure 83. Global Active Pharma Ingredient Sales and Growth Rate (2021-2025) (MT)
Figure 84. Global Active Pharma Ingredient Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Active Pharma Ingredient Market Forecast (2021-2025) (MT)
Figure 86. Europe Sales Active Pharma Ingredient Market Forecast (2021-2025) (MT)
Figure 87. Asia-Pacific Sales Active Pharma Ingredient Market Forecast (2021-2025) (MT)
Figure 88. South America Sales Active Pharma Ingredient Market Forecast (2021-2025) (MT)
Figure 89. Middle East & Africa Sales Active Pharma Ingredient Market Forecast (2021-2025) (MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
医薬品有効成分の世界市場（～2026年） Market Analysis and Insights: Global Active Pharma Ingredient Market The global Active Pharma Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Active Pharma Ingredient Scope and Market Size Active Pharma Ingr…- インスリン有効成分の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Insulin Active Pharmaceutical Ingredient market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Insu…
- インスリン有効成分の世界市場（～2026年） Market Analysis and Insights: Global Insulin Active Pharmaceutical Ingredient Market The global Insulin Active Pharmaceutical Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Active Pharmaceutical Ing…
- ジェネリック医薬品有効成分の世界市場（～2026年） Market Analysis and Insights: Global Generic Active Pharmaceutical Ingredients Market The global Generic Active Pharmaceutical Ingredients market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Generic Active Pharmaceutical I…
- 高薬理活性原薬 (HPAPI)の世界市場（～2026年） The drugs are classified as High Potent if its Occupational Exposure Limit (OELs) = 10µg/m3. Market Analysis and Insights: Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market The global High Potency Active Pharmaceutical Ingredients (HPAPI) market size is projected to reach US$ XX m…